PanoramicaGraficoProfiloStatistiche chiaveDati finanziariNotizie
Derivati
SchermataTrader

RUBIS/  FR0013269123  /

Nasdaq Other OTC
18/04/2024  19:42:55 Var. - Volume Denaro- Lettera- Capitalizzazione di mercato Dividend Y. Rapporto P/E
33.5500USD - 760
Fatturato: 25,498		 -Quantità in denaro: - -Quantità in lettera: - 2.44 bill.USD - -
GlobeNewswire 08/11/2023 Hemper and 40 Tons Launch Rolling Tray Collab to Raise Awareness for Incarcerated Individuals
Newsfile Corp 04/10/2023 The New Immersive Exhibition, A Portal for Healing, Opening at theART-Dept. In West Hollywood Octobe...
GlobeNewswire 21/05/2021 Athenex Announces Klisyri® (tirbanibulin) Receives Positive CHMP Opinion from the European Medicines...
GlobeNewswire 17/05/2021 Athenex, Texas Children’s Cancer Center, and the Center for Cell and Gene Therapy at Baylor College ...
GlobeNewswire 06/05/2021 Athenex Provides First Quarter 2021 Corporate and Financial Update
GlobeNewswire 04/05/2021 Athenex to Acquire Kuur Therapeutics to Expand Cell Therapy Development with Off-the-Shelf Engineere...
GlobeNewswire 27/04/2021 Athenex to Provide Corporate and Financial Update for the First Quarter 2021 on May 6, 2021
GlobeNewswire 01/03/2021 Athenex Provides Fourth Quarter and Full Year 2020 Corporate and Financial Update
GlobeNewswire 01/03/2021 Athenex Receives FDA Complete Response Letter for Oral Paclitaxel Plus Encequidar for the Treatment ...
GlobeNewswire 22/02/2021 Athenex to Provide a Corporate and Financial Update for the Fourth Quarter and Full Year 2020 on Mar...
GlobeNewswire 18/02/2021 Athenex Announces U.S. Launch of Klisyri® and Licensing of Additional Territories for Tirbanibulin
GlobeNewswire 11/02/2021 Athenex Announces New England Journal of Medicine Publication of Phase III Data on the Efficacy and ...
GlobeNewswire 25/01/2021 CEO Dr. Johnson Lau Recuperating from COVID at Home
GlobeNewswire 08/01/2021 CEO Dr. Johnson Lau Contracts COVID-19
GlobeNewswire 05/01/2021 Athenex to Present at the 39th Annual J.P. Morgan Healthcare Conference
GlobeNewswire 15/12/2020 Athenex Announces FDA Approval of Klisyri® (Tirbanibulin) for the Treatment of Actinic Keratosis on ...
GlobeNewswire 09/12/2020 Athenex Presents Updated Phase 3 Data on Survival and Tolerability Associated with Oral Paclitaxel a...
GlobeNewswire 02/12/2020 Athenex Pharmaceutical Division and Ingenus Pharmaceuticals Announce Availability of Liquid, Ready t...
GlobeNewswire 17/11/2020 Athenex Announces Data on Oral Paclitaxel and Encequidar to be Presented at the 2020 San Antonio Bre...
GlobeNewswire 05/11/2020 Athenex, Inc. Reports Third Quarter Ended September 30, 2020 Financial Results and Provides Corporat...
GlobeNewswire 22/10/2020 Athenex, Inc. to Report Third Quarter 2020 Earnings Results on November 5, 2020
GlobeNewswire 12/10/2020 Axis Therapeutics Announces Research Collaboration with PharmaEssentia for Development of TCR-T Cell...
GlobeNewswire 29/04/2019 The Kenyan Petroleum Industry 2019: State & Size of the Industry, Influencing Factors, and Competiti...
GlobeNewswire 19/01/2018 RUBIS: Issue of new shares (Equity Line)
GlobeNewswire 12/01/2018 RUBIS : BITUMEN BUSINESS GETS MORE INTERNATIONAL